|
1
|
Badimon L, Chagas P and Chiva-Blanch G:
Diet and cardiovascular disease: Effects of foods and nutrients in
classical and emerging cardiovascular risk factors. Curr Med Chem.
26:3639–3651. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Xu L, Su Y, Zhao Y, Sheng X, Tong R, Ying
X, Gao L, Ji Q, Gao Y, Yan Y, et al: Melatonin differentially
regulates pathological and physiological cardiac hypertrophy:
Crucial role of circadian nuclear receptor RORα signaling. J Pineal
Res. 67(e12579)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Shimizu I and Minamino T: Physiological
and pathological cardiac hypertrophy. J Mol Cell Cardiol.
97:245–262. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Heineke J and Molkentin JD: Regulation of
cardiac hypertrophy by intracellular signalling pathways. Nat Rev
Mol Cell Biol. 7:589–600. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Nakamura M and Sadoshima J: Mechanisms of
physiological and pathological cardiac hypertrophy. Nat Rev
Cardiol. 15:387–407. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tsuruda T, Sekita-Hatakeyama Y, Hao Y,
Sakamoto S, Kurogi S, Nakamura M, Udagawa N, Funamoto T, Sekimoto
T, Hatakeyama K, et al: Angiotensin II stimulation of cardiac
hypertrophy and functional decompensation in
osteoprotegerin-deficient mice. Hypertension. 67:848–856.
2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Luo YX, Tang X, An XZ, Xie XM, Chen XF,
Zhao X, Hao DL, Chen HZ and Liu DP: SIRT4 accelerates Ang
II-induced pathological cardiac hypertrophy by inhibiting manganese
superoxide dismutase activity. Eur Heart J. 38:1389–1398.
2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Liu Y, Jiao R, Ma ZG, Liu W, Wu QQ, Yang
Z, Li FF, Yuan Y, Bian ZY and Tang QZ: Sanguinarine inhibits
angiotensin II-induced apoptosis in H9c2 cardiac cells via
restoring reactive oxygen species-mediated decreases in the
mitochondrial membrane potential. Mol Med Rep. 12:3400–3408.
2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Murphy E, Ardehali H, Balaban RS, DiLisa
F, Dorn GW II, Kitsis RN, Otsu K, Ping P, Rizzuto R, Sack MN, et
al: Mitochondrial function, biology, and role in disease: A
scientific statement from the American heart association. Circ Res.
118:1960–1991. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Peoples JN, Saraf A, Ghazal N, Pham TT and
Kwong JQ: Mitochondrial dysfunction and oxidative stress in heart
disease. Exp Mol Med. 51:1–13. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Cai J, Shi G, Zhang Y, Zheng Y, Yang J,
Liu Q, Gong Y, Yu D and Zhang Z: Taxifolin ameliorates DEHP-induced
cardiomyocyte hypertrophy via attenuating mitochondrial dysfunction
and glycometabolism disorder in chicken. Environ Pollut.
255(113155)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tian H, Yu D, Hu Y, Zhang P, Yang Y, Hu Q
and Li M: Angiotensin II upregulates cyclophilin A by enhancing ROS
production in rat cardiomyocytes. Mol Med Rep. 18:4349–4355.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hao P, Jiang F, Cheng J, Ma L, Zhang Y and
Zhao Y: Traditional Chinese medicine for cardiovascular disease:
Evidence and potential mechanisms. J Am Coll Cardiol. 69:2952–2966.
2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gao S, Liu Z, Li H, Little PJ, Liu P and
Xu S: Cardiovascular actions and therapeutic potential of
tanshinone IIA. Atherosclerosis. 220:3–10. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tan X, Li J, Wang X, Chen N, Cai B, Wang
G, Shan H, Dong D, Liu Y, Li X, et al: Tanshinone IIA protects
against cardiac hypertrophy via inhibiting calcineurin/NFATc3
pathway. Int J Biol Sci. 7:383–389. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Huang XY and Chen CX: Effect of
oxymatrine, the active component from Radix Sophorae flavescentis
(Kushen), on ventricular remodeling in spontaneously hypertensive
rats. Phytomedicine. 20:202–212. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Liu Y, Liang S, Bu P, Liang E, Yan F, Xing
Y and Zhang P: Radix Puerariae rebalances vasomotor factors
and improves left ventricular diastolic dysfunction in patients
with essential hypertension. Exp Ther Med. 20:705–713.
2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang J, Dong ZH, Gui MT, Yao L, Li JH,
Zhou XJ and Fu DY: HuoXue QianYang QuTan recipe attenuates left
ventricular hypertrophy in obese hypertensive rats by improving
mitochondrial function through SIRT1/PGC-1α deacetylation pathway.
Biosci Rep. 39(BSR20192909)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhou X, Lu B, Fu D, Gui M, Yao L and Li J:
Huoxue Qianyang decoction ameliorates cardiac remodeling in obese
spontaneously hypertensive rats in association with ATF6-CHOP
endoplasmic reticulum stress signaling pathway regulation. Biomed
Pharmacother. 121(109518)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Vaskova E, Ikeda G, Tada Y, Wahlquist C,
Mercola M and Yang PC: Sacubitril/valsartan improves cardiac
function and decreases myocardial fibrosis via downregulation of
exosomal miR-181a in a rodent chronic myocardial infarction model.
J Am Heart Assoc. 9(e015640)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ehler E, Moore-Morris T and Lange S:
Isolation and culture of neonatal mouse cardiomyocytes. J Vis Exp.
(50154)2013.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Xing L and Li Z: Angiotensin II induced
myocardial hypertrophy in neonatal rats could be attenuated by
activated κ-opioid receptor via modulating the calcineurin signal
pathways. Zhonghua Xin Xue Guan Bing Za Zhi. 43:254–258.
2015.PubMed/NCBI(In Chinese).
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Li H, Sureda A, Devkota HP, Pittalà V,
Barreca D, Silva AS, Tewari D, Xu S and Nabavi SM: Curcumin, the
golden spice in treating cardiovascular diseases. Biotechnol Adv.
38(107343)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Xiong X, Yang X, Duan L, Liu W, Zhang Y,
Liu Y, Wang P, Li S and Li X: Traditional Chinese medicine
suppresses left ventricular hypertrophy by targeting extracellular
signal-regulated kinases signaling pathway in spontaneously
hypertensive rats. Sci Rep. 7(42965)2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Huang R, Cui YC, Wei XH, Pan CS, Li Q, He
SY, Fan JY and Han JY: A novel traditional Chinese medicine
ameliorates fatigue-induced cardiac hypertrophy and dysfunction via
regulation of energy metabolism. Am J Physiol Heart Circ Physiol.
316:H1378–H1388. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Gao RR, Wu XD, Jiang HM, Zhu YJ, Zhou YL,
Zhang HF, Yao WM, Li YQ and Li XL: Traditional Chinese medicine
Qiliqiangxin attenuates phenylephrine-induced cardiac hypertrophy
via upregulating PPARγ and PGC-1α. Ann Transl Med.
6(153)2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zou R, Tao J, Qiu J, Shi W, Zou M, Chen W,
Li W, Zhou N, Wang S, Ma L and Chen X: Ndufs1 deficiency aggravates
the mitochondrial membrane potential dysfunction in pressure
overload-induced myocardial hypertrophy. Oxid Med Cell Longev.
2021(5545261)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Thirupathi A and de Souza CT:
Multi-regulatory network of ROS: The interconnection of ROS, PGC-1
alpha, and AMPK-SIRT1 during exercise. J Physiol Biochem.
73:487–494. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
St-Pierre J, Drori S, Uldry M, Silvaggi
JM, Rhee J, Jäger S, Handschin C, Zheng K, Lin J, Yang W, et al:
Suppression of reactive oxygen species and neurodegeneration by the
PGC-1 transcriptional coactivators. Cell. 127:397–408.
2006.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Rababa'h AM, Guillory AN, Mustafa R and
Hijjawi T: Oxidative stress and cardiac remodeling: An updated
edge. Curr Cardiol Rev. 14:53–59. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Gallo S, Vitacolonna A, Bonzano A,
Comoglio P and Crepaldi T: ERK: A key player in the pathophysiology
of cardiac hypertrophy. Int J Mol Sci. 20(2164)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Singh RM, Cummings E, Pantos C and Singh
J: Protein kinase C and cardiac dysfunction: A review. Heart Fail
Rev. 22:843–859. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lee Y, Jeong GS, Kim KM, Lee W and Bae JS:
Cudratricusxanthone A attenuates sepsis-induced liver injury via
SIRT1 signaling. J Cell Physiol. 233:5441–5446. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Cui L, Guo J, Zhang Q, Yin J, Li J, Zhou
W, Zhang T, Yuan H, Zhao J, Zhang L, et al: Erythropoietin
activates SIRT1 to protect human cardiomyocytes against
doxorubicin-induced mitochondrial dysfunction and toxicity. Toxicol
Lett. 275:28–38. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhang T, Chi Y, Ren Y, Du C, Shi Y and Li
Y: Resveratrol reduces oxidative stress and apoptosis in podocytes
via Sir2-related enzymes, sirtuins1 (SIRT1)/peroxisome
proliferator-activated receptor γ co-activator 1α (PGC-1α) axis.
Med Sci Monit. 25:1220–1231. 2019.PubMed/NCBI View Article : Google Scholar
|
